My Quote Request
6505-01-071-2521
20 Products
QUINAGLUTE DURA-TAB
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
QUINAGLUTE DURA-TAB
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE;LONG ACTION MEHTOD:EXTENDED RELEASE;ADMINISTRATION ORAL NONCHEWABLE;
Related Searches:
NDC00093-0674-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC00093-0674-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC00182-1864-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC00182-1864-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC00182-1864-89
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC00182-1864-89
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
IVAX
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC00555-0607-02
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC00555-0607-02
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC00904-3571-61
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC00904-3571-61
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC49884-0290-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC49884-0290-01
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC51079-0435-20
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
NDC51079-0435-20
MEGESTROL ACETATE TABLETS,USP
NSN, MFG P/N
6505010701493
NSN
6505-01-070-1493
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS MEGESTROL ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEGESTROL ACETATE TABLETS USP 40 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
Related Searches:
NDC00314-0607-70
ATROPINE SULFATE INJECTION,USP
NSN, MFG P/N
6505010701525
NSN
6505-01-070-1525
NDC00314-0607-70
ATROPINE SULFATE INJECTION,USP
NSN, MFG P/N
6505010701525
NSN
6505-01-070-1525
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS ATROPINE SULFATE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MULTIPLE DOSE BOTTLE
Related Searches:
D226
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505010701634
NSN
6505-01-070-1634
MFG
SANOFI-SYNTHELABO INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.713 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.020 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.50 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DANAZOL CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00024-0305-06
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505010701634
NSN
6505-01-070-1634
NDC00024-0305-06
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505010701634
NSN
6505-01-070-1634
MFG
SANOFI-SYNTHELABO INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.713 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.020 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.50 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DANAZOL CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00555-0635-02
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505010701634
NSN
6505-01-070-1634
NDC00555-0635-02
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505010701634
NSN
6505-01-070-1634
MFG
BARR PHARMACEUTICALS LLC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.713 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.020 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.50 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DANAZOL CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
C035
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010702782
NSN
6505-01-070-2782
C035
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010702782
NSN
6505-01-070-2782
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
Related Searches:
VOSOL HC OTIC SOLUTION
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010702782
NSN
6505-01-070-2782
VOSOL HC OTIC SOLUTION
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
NSN, MFG P/N
6505010702782
NSN
6505-01-070-2782
MFG
BAYLOR LABORATORIES INC
Description
ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION
Related Searches:
NDC0252-2066-01
AMINOACETIC ACID AND CALCIUM CARBONATE SUSPENSION
NSN, MFG P/N
6505010705177
NSN
6505-01-070-5177
NDC0252-2066-01
AMINOACETIC ACID AND CALCIUM CARBONATE SUSPENSION
NSN, MFG P/N
6505010705177
NSN
6505-01-070-5177
MFG
DEPT OF HEALTH EDUCATION AND WELFARE FOOD AND DRUG ADMINISTRATION BUREAU OF DRUGS REGISTRATION SECTION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.420 GRAMS CALCIUM CARBAMATE ACTIVE INGREDIENT AND 0.180 GRAMS GLYCINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: TABLETS 100.000
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COLOR WHITE;CHEWABLE
Related Searches:
NDC00054-3408-40
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505010705807
NSN
6505-01-070-5807
NDC00054-3408-40
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505010705807
NSN
6505-01-070-5807
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V ISOETHARINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL INHALATION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOETHARINE INHALATION SOLUTION USP 1% 10ML
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS AND GLYCERIN
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
SPECIAL FEATURES: CONTAINS SODIUM CHLORIDE,CITRIC ACID,AND SODIUM HYDROXIDE; WITH METHYLPARABEN,PROPYLPARABEN,AND ACETONE SODIUM BISULFITE; WITH DROPPER CAAABRATED AT 0.25 ML ANN 0.5 ML
Related Searches:
NDC0074-4888-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010710205
NSN
6505-01-071-0205
NDC0074-4888-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010710205
NSN
6505-01-071-0205
MFG
ABBOTT LABORATORIES ABBOTT SCIENTIFIC PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-3113-42
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
NDC00005-3113-42
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE;LONG ACTION MEHTOD:EXTENDED RELEASE;ADMINISTRATION ORAL NONCHEWABLE;
Related Searches:
NDC00591-5538-90
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
NDC00591-5538-90
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
MFG
DANBURY PHARMACAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE;LONG ACTION MEHTOD:EXTENDED RELEASE;ADMINISTRATION ORAL NONCHEWABLE;
Related Searches:
NDC50419-0101-09
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
NDC50419-0101-09
QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010712521
NSN
6505-01-071-2521
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE;LONG ACTION MEHTOD:EXTENDED RELEASE;ADMINISTRATION ORAL NONCHEWABLE;